Marker Therapeutics Inc (NASDAQ: MRKR) stock closed at $3.39 on 8/13/24 after a major decline of -11.3%. However, below average trading volume at 79% of normal accompanied the decline. The stock has been strong relative to the market over the last nine months but has declined -13.1% during the last week.
Current PriceTarget Research Rating
With future capital returns forecasted to fall short of the cost of capital, MRKR is expected to be a modest Value Eraser.
Marker Therapeutics has a current Value Trend Rating of D (Negative). This rating combines very contradictory signals from two proprietary PTR measures of a stock’s attractiveness. Marker Therapeutics has a very low Appreciation Score of 7 but a good Power Rating of 75, resulting in the Negative Value Trend Rating.
Rating Review
In light of this highly negative price change we are reviewing our current Overall Rating of D. This review will be completed in the next several days.
Be the first to comment